Andrew Guggenhime - 07 Apr 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
PRESIDENT AND CFO
Signature
Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
07 Apr 2025
Net transactions value
+$99,983
Form type
4
Filing time
09 Apr 2025, 08:05:12 UTC
Previous filing
03 Mar 2025
Next filing
04 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $99,983 +4,777 +3.8% $20.93 131,950 07 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -4,777 -3.8% $0.000000 121,115 07 Apr 2025 Common Stock 4,777 $20.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock Option is fully vested and exercisable.